CJC-1295 + Ipamorelin
A small healthy-volunteer trial showed CJC-1295 could raise GH and IGF-1. It did not establish better sleep, injury recovery, muscle gain or longevity. Neither this stack nor its wellness use is FDA-approved: calling it off-label incorrectly implies an approved medicine.
CJC-1295 studied with its drug-affinity complex is not interchangeable with products marketed as no-DAC. No validated combined wellness regimen. FDA flags CJC-1295 safety events and insufficient information for other injectable routes of ipamorelin.
